Alerts
Modified Hours for Labor Day

In recognition of the upcoming Labor Day holiday, some of The University of Kansas Cancer Center’s offices will have modified hours on Monday, September 1, 2025.

Skip Navigation

A Phase Ib/II trial of Onvansertib in Combination with NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT06736717

Study #:
STUDY00161071

Start Date:
Jan 28, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06736717

View Complete Trial Details & Eligibility at ClinicalTrials.gov